Jiangsu Lintex Advanced Materials
920106
Beijing Chieftain Control Technology Group
300430
Jiangsu Apon Medical Technology
300753
SigmaStar Technology
301536
Jiangsu Jingxue Insulation Technology
301010
CN Stock MarketDetailed Quotes
301228 SEP Analytical
- 16.24
- +0.80+5.18%
Noon Break Dec 18 11:30 CST
1.95BMarket Cap-31.17P/E (TTM)
16.48High14.21Low135.65KlotVolume15.04Open15.44Pre Close207.80MTurnover24.77%Turnover RatioLossP/E (Static)120.00MShares17.7952wk High2.60P/B889.42MFloat Cap6.9252wk Low18.53Limit Up54.77MShs Float47.02Historical High12.35Limit Down14.70%Amplitude6.92Historical Low--Dividend TTM15.32Avg Price61.28KlotAsk--Div YieldTTM100Lot Size65.17KlotBid
SEP Analytical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 22.92%307.08M | 17.13%198.98M | 8.06%76.28M | 6.36%373.83M | 18.62%249.82M | 39.78%169.87M | 28.65%70.59M | -17.28%351.47M | -20.61%210.6M | -25.89%121.53M |
| Operating revenue | 22.92%307.08M | 17.13%198.98M | 8.06%76.28M | 6.36%373.83M | 18.62%249.82M | 39.78%169.87M | 28.65%70.59M | -17.28%351.47M | -20.61%210.6M | -25.89%121.53M |
| Other operating revenue | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
| Total operating cost | 2.30%318.27M | -2.94%208.07M | -7.33%89.41M | 22.33%437.35M | 35.42%311.12M | 44.87%214.39M | 41.81%96.48M | 0.60%357.5M | -2.02%229.75M | -1.48%147.98M |
| Operating cost | 9.42%219.64M | 2.07%142.06M | -11.62%54.06M | 27.07%297.29M | 42.79%200.73M | 69.40%139.17M | 55.99%61.16M | -7.74%233.96M | -12.50%140.58M | -16.45%82.16M |
| Operating tax surcharges | 52.76%722.31K | 24.13%442.48K | -15.83%209.91K | 151.47%964.93K | 228.21%472.84K | 291.58%356.48K | 402.55%249.37K | 68.49%383.72K | -4.61%144.07K | 3,802.69%91.04K |
| Operating expense | -5.09%38.5M | -6.68%25.06M | 34.99%17.18M | 38.17%57.42M | 42.47%40.57M | 38.00%26.86M | 28.06%12.73M | 2.72%41.56M | -4.93%28.48M | -3.95%19.46M |
| Administration expense | -0.58%34.66M | -1.54%23.21M | -19.69%8M | 14.84%43.47M | 30.34%34.86M | 26.09%23.57M | 47.13%9.96M | 42.68%37.85M | 51.23%26.75M | 51.94%18.7M |
| Financial expense | 42.08%916.7K | 128.50%557.38K | 172.00%121.91K | -46.41%972.2K | 322.86%645.2K | -78.42%243.93K | 105.95%44.82K | -40.70%1.81M | -113.68%-289.5K | -22.06%1.13M |
| -Interest expense (Financial expense) | 47.43%1.31M | 72.49%908.93K | -16.47%234.67K | -13.82%1.14M | -10.07%890.95K | -26.04%526.95K | -25.37%280.95K | -34.11%1.32M | -35.50%990.76K | -36.34%712.49K |
| -Interest Income (Financial expense) | 51.09%-794.87K | 9.80%-1.08M | 28.33%-503.84K | -29.08%-2.12M | 42.12%-1.63M | -97.35%-1.19M | 57.72%-703K | -242.78%-1.64M | -563.74%-2.81M | -79.40%-605.4K |
| Research and development | -29.60%23.82M | -30.78%16.74M | -20.23%9.84M | -11.21%37.24M | -0.75%33.84M | -8.58%24.18M | -3.79%12.34M | 33.10%41.93M | 42.54%34.09M | 48.15%26.45M |
| Credit Impairment Loss | -18.58%-35.28M | -31.90%-22.3M | -129.47%-7.29M | -21.73%-46.66M | -15.42%-29.75M | -7.78%-16.9M | 45.84%-3.18M | -166.33%-38.33M | -223.11%-25.78M | -434.20%-15.68M |
| Asset Impairment Loss | 90.69%-149.51K | 44.45%-591.33K | -268.39%-390.51K | -357.80%-4.56M | -47.69%-1.61M | -13.15%-1.06M | 81.12%-106K | 23.74%-995.72K | 16.71%-1.09M | 1.65%-940.9K |
| Other net revenue | -36.69%-34.8M | -59.65%-21.69M | -1,591.65%-7.22M | -122.69%-39.9M | -54.21%-25.46M | -27.53%-13.59M | 108.17%484.03K | -41.52%-17.91M | -111.10%-16.51M | -284.85%-10.65M |
| Fair value change income | 61.73%-85.65K | -111.88%-139.55K | -279.55%-69.2K | -64.66%338.83K | -136.27%-223.78K | -25.22%-65.86K | 66.88%-18.23K | --958.87K | ---94.71K | ---52.6K |
| Invest income | -116.78%-661.58K | -70.05%857.71K | -87.19%271.95K | -49.11%5.13M | -26.01%3.94M | 12.92%2.86M | 3,876.90%2.12M | 37,185.31%10.07M | 19,627.44%5.33M | 9,287.46%2.54M |
| -Including: Investment income associates | ---- | -41.60%-937.32K | ---- | -1,299.86%-313.6K | ---- | ---661.96K | ---- | ---22.4K | ---- | ---- |
| Asset deal income | 97.34%-19.32K | 90.49%-60.41K | ---- | -73.05%-479.15K | -162.53%-726.89K | -129.52%-635.48K | 104.15%11.5K | -146.36%-276.88K | -132.09%-276.88K | -132.09%-276.88K |
| Other revenue | -51.95%1.4M | -75.59%542.31K | -84.26%259.96K | -40.49%6.34M | -46.15%2.91M | -41.00%2.22M | 110.22%1.65M | 241.10%10.66M | 247.14%5.4M | 209.44%3.77M |
| Operating profit | 47.00%-45.98M | 47.01%-30.79M | 19.90%-20.35M | -331.83%-103.41M | -143.30%-86.76M | -56.57%-58.1M | -33.10%-25.4M | -142.13%-23.95M | -255.27%-35.66M | -436.74%-37.11M |
| Add:Non operating Income | 19,350.90%822.25K | 5,688.17%551.76K | 67.09%27.91K | 6,676.54%342.26K | 681,725.81%4.23K | 95,324,500.00%9.53K | 7,591,668.18%16.7K | -11.41%5.05K | 106.67%0.62 | -96.67%0.01 |
| Less:Non operating expense | 56.37%661.7K | 648.49%584.71K | 527.61%478.39K | 106.50%1.61M | -89.82%423.17K | -98.10%78.12K | 568,740.15%76.22K | -14.59%779.32K | 356.80%4.16M | 361.73%4.12M |
| Total profit | 47.44%-45.82M | 47.01%-30.82M | 18.32%-20.8M | -323.43%-104.68M | -118.96%-87.18M | -41.09%-58.17M | -33.41%-25.46M | -144.19%-24.72M | -280.52%-39.81M | -507.09%-41.23M |
| Less:Income tax cost | 52.68%-8.73M | 54.79%-5.68M | 48.98%-2.78M | -85.79%-16.72M | -93.28%-18.46M | -38.64%-12.56M | -23.72%-5.44M | -279.80%-9M | -1,309.91%-9.55M | -1,442.15%-9.06M |
| Net profit | 46.03%-37.09M | 44.87%-25.14M | 9.98%-18.02M | -459.45%-87.96M | -127.06%-68.72M | -41.79%-45.61M | -36.31%-20.02M | -130.87%-15.72M | -242.30%-30.26M | -400.22%-32.17M |
| Net profit from continuing operation | 46.03%-37.09M | 44.87%-25.14M | 9.98%-18.02M | -459.45%-87.96M | -127.06%-68.72M | -41.79%-45.61M | -36.31%-20.02M | -130.87%-15.72M | -242.30%-30.26M | -400.22%-32.17M |
| Less:Minority Profit | 53,859.42%641.99K | 452.53%1.19M | -723.75%-1.77M | 149.43%5.58M | -98.91%1.19K | -212.05%-337.47K | 220.10%284.56K | 346.04%2.24M | 185.44%109.26K | -3.49%-108.14K |
| Net profit of parent company owners | 45.09%-37.73M | 41.83%-26.33M | 19.99%-16.25M | -420.84%-93.54M | -126.25%-68.72M | -41.21%-45.27M | -40.51%-20.3M | -135.61%-17.96M | -243.07%-30.37M | -396.33%-32.06M |
| Earning per share | ||||||||||
| Basic earning per share | 45.61%-0.31 | 39.92%-0.2267 | 19.98%-0.1354 | -420.00%-0.78 | -119.23%-0.57 | -34.75%-0.3773 | -30.15%-0.1692 | -126.79%-0.15 | -208.33%-0.26 | -333.33%-0.28 |
| Diluted earning per share | 45.61%-0.31 | 39.92%-0.2267 | 19.98%-0.1354 | -420.00%-0.78 | -119.23%-0.57 | -34.75%-0.3773 | -30.15%-0.1692 | -126.79%-0.15 | -208.33%-0.26 | -333.33%-0.28 |
| Other composite income | ||||||||||
| Total composite income | 46.03%-37.09M | 44.87%-25.14M | 9.98%-18.02M | -459.45%-87.96M | -127.06%-68.72M | -41.79%-45.61M | -36.31%-20.02M | -130.87%-15.72M | -242.30%-30.26M | -400.22%-32.17M |
| Total composite income of parent company owners | 45.09%-37.73M | 41.83%-26.33M | 19.99%-16.25M | -420.84%-93.54M | -126.25%-68.72M | -41.21%-45.27M | -40.51%-20.3M | -135.61%-17.96M | -243.07%-30.37M | -396.33%-32.06M |
| Total composite income of minority owners | 53,859.42%641.99K | 452.53%1.19M | -723.75%-1.77M | 149.43%5.58M | -98.91%1.19K | -212.05%-337.47K | 220.10%284.56K | 346.04%2.24M | 185.44%109.26K | -3.49%-108.14K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
